-+ 0.00%
-+ 0.00%
-+ 0.00%

ESTRELLA IMMUNOPHARMA ACTIVATES UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER AS FOURTH CLINICAL SITE FOR PHASE I/II STARLIGHT-1 TRIAL IN B-CELL NON-HODGKIN’S LYMPHOMA

Reuters·08/11/2026 12:00:03

Please log in to view news